Company / Total Assets
Stoke Therapeutics, Inc. Total Assets History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$418.4M
FY2025
5-year range
$228.3M / $418.4M
FY2021-FY2025
Trend
+54.1%
vs FY2024
Sector context
#154 of 214
Health Care
What the data says
At $418M, Stoke Therapeutics, Inc.'s total assets ranks #154 of 214 in the Health Care sector. Total Assets has fluctuated over the past 8 years, ranging from $108M in FY2018 to $418M in FY2025.
Based on SEC 10-K filings.
$418M in FY2025 with a 5-year CAGR of +7.0%.
Improved from $228M to $418M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +17.8%
- 5-Year CAGR
- +7.0%
- 10-Year CAGR
- -
Sector benchmark
#154 of 214 in Health CareTop 72% of 214This company $418.4M Sector average $7.5B
▼
-94.4% below sector average
Key checks
Key Insights
- 5-year CAGR of +7.0%, indicating consistent growth.
- In FY2025, total assets increased 54.1% year-over-year.
- Ranks #154 out of 214 companies in the Health Care sector.
- Lowest total assets in the period was in FY2018.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $418.4M | +54.1% |
| FY2024 | $271.6M | +18.9% |
| FY2023 | $228.3M | -10.8% |
| FY2022 | $256.1M | +7.2% |
| FY2021 | $238.9M | -19.8% |
| FY2020 | $297.9M | +30.2% |
| FY2019 | $228.8M | +112.7% |
| FY2018 | $107.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026